Operating an unlicensed private blood transfusion or plasmapheresis centre in Nigeria constitutes a grave criminal offence under the National Blood Service Agency Act 2021 and the National Health Act 2014, punishable by immediate facility closure, confiscation of medical equipment, administrative fines of not less than one million Naira, and imprisonment of principal officers and medical personnel for terms between one and five years. The unauthorized commercial collection, fractionation, processing, or transfusion of human blood and plasma without valid regulatory certification poses critical public health hazards that trigger concurrent administrative sanctions and criminal prosecutions under Nigerian law.
Statutory and Regulatory Framework
The legislative foundation governing blood safety in Nigeria rests primarily on the National Blood Service Agency (NBSA) Act 2021, which established the NBSA as the sole statutory authority responsible for regulating, coordinating, and ensuring the safety of all blood collection, testing, processing, and distribution activities across the Federation.
Sections 22 through 30 of the National Health Act 2014 explicitly regulate the procurement, storage, and handling of human tissue and blood products. Under Section 23 of the National Health Act, commercial trading or unauthorized exploitation of human blood, plasma, or tissues is expressly prohibited, classifying blood as a strictly regulated national biological resource rather than a commercial commodity.
At the sub-national level, state regulatory authorities, such as the Health Facility Monitoring and Accreditation Agency (HEFAMAA) in Lagos State and equivalent state blood transfusion boards, possess concurrent statutory powers to inspect, accredit, and seal healthcare establishments that fail to meet minimum clinical standards.
Specific Statutory Violations and Prohibited Practices
Operating outside the regulatory grid generally involves multiple severe statutory infractions that compound the liability of offending operators.
The unlawful practice of engaging commercial remunerated donors, commonly known in commercial circles as blood quarrying, violates national blood safety guidelines. Unlicensed facilities routinely fail to adhere to mandatory screening protocols for Transfusion-Transmissible Infections (TTIs), which require chemiluminescence enzyme immunoassays or Nucleic Acid Testing (NAT) for HIV 1 and 2, Hepatitis B, Hepatitis C, and Treponema pallidum.
Plasmapheresis involves specialized apheresis machinery that extracts whole blood, separates and retains plasma components, and re-infuses cellular elements back into the donor. Performing this complex biological separation without certified automated cell separators, donor venous access safety controls, and continuous medical supervision represents gross clinical endangerment.
Step-by-Step Regulatory Enforcement and Prosecution Procedure
- Surveillance and Intelligence Gathering: Regulatory inspectors from the NBSA, state health surveillance units, or law enforcement task forces receive public complaints or intelligence regarding unlicensed blood sales and donor exploitation.
- Inter-Agency Enforcement Raid: Regulatory officials, accompanied by the Nigeria Police Force and public health officers, execute an enforcement search warrant on the premises.
- Physical Facility Sealing and Evidence Evacuation: The premises are officially sealed with regulatory tape; improperly stored blood units, apheresis kits, unvalidated centrifuge machines, donor payment ledgers, and testing reagents are impounded as judicial exhibits.
- Arrest and Interrogation of Personnel: Attending clinical personnel, laboratory technicians, and facility administrators are taken into custody and interrogated regarding operating licenses and medical qualifications.
- Administrative Sanctions and Regulatory Blacklisting: The NBSA issues formal notices of cancellation or permanent blacklisting, barring the promoter from applying for medical laboratory or blood banking licenses.
- Filing of Formal Criminal Charges: The state attorney general or the Federal Ministry of Justice files criminal charges at the Federal High Court or State High Court for operating an unlicensed health facility, endangering human lives, and commercial blood trafficking.
- Professional Tribunal Disciplinary Prosecution: Indicted healthcare practitioners are reported to the Medical and Dental Council of Nigeria (MDCN) or the Medical Laboratory Science Council of Nigeria (MLSCN) for license revocation.
Comparison of Regulatory Standards for Blood Facilities
- Routine Blood Transfusion Service: Mandates certified whole blood collection bays, dedicated cold chain storage maintained strictly between two and six degrees Celsius, validated blood grouping serology, and rapid cross-matching facilities.
- Commercial Plasmapheresis Operation: Requires automated apheresis machines with single-use sterile disposable sets, continuous physician monitoring of donor fluid shifts, emergency volume resuscitation equipment, and deep frozen plasma storage maintained below minus twenty degrees Celsius.
- Donor Protection Framework: Standard blood banks observe a mandatory twelve-week donation interval for whole blood, whereas plasmapheresis establishments require donor serum protein electrophoresis testing before serial plasma donations.
- Facility Accreditation Scope: Routine hospitals require basic health facility registration, whereas dedicated blood processing and plasma fraction extraction centers must hold specialized tier-one NBSA operational certificates.
Establishing a Lawfully Compliant Blood Centre
Promoters intending to operate private blood banking and component preparation services must follow a rigorous pathway to ensure total legal compliance.
The enterprise must first be incorporated as a private limited company with the Corporate Affairs Commission (CAC) with authorized share capital reflecting technical healthcare services. The company must engage an MDCN-registered consultant haematologist or certified medical laboratory scientist to serve as the designated technical director. The facility must undergo pre-inspection by the relevant State Ministry of Health, obtain structural layout approval, install validated temperature-monitored cold storage units, and secure formal operational accreditation from the NBSA before admitting donors or distributing blood products.